Gary Zieziula
Director/Board Member at INNOVENT BIOLOGICS, INC.
Net worth: 23 851 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| De Chao Yu | M | 61 | 13 years | |
| Hao Xi Ede | M | 65 | 7 years | |
| Charles Cooney | M | 80 | 9 years | |
| I Yin Hsu | F | 50 | 6 years | |
| Kai Xian Chen | M | 78 | 6 years | |
| Ravi Kiron | M | 64 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| Yong-Jun Liu | M | - | 4 years | |
| Fei You | F | 45 | - | |
| Lok Yee Chan | F | 35 | 6 years | |
| Qin Wei Zhou | M | 61 | 8 years | |
| Yan Ju Wang | F | 36 | 9 years | |
| Blake Salisbury | M | - | 8 years | |
| Vivian Zhang | F | - | 12 years | |
| Chris Round | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| Ghang Shou Gao | M | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Thomas | M | 54 | 6 years | |
| Scott A. Holmes | M | 50 | 4 years | |
| Brian Pereira | M | 65 | 7 years | |
| Craig Shular | M | 71 |
State University of New York at Buffalo
| 6 years |
| David A. Dooley | M | - |
State University of New York at Buffalo
| 6 years |
| Edward C. English | M | 57 | 4 years | |
| Harry Patrick Barnum | M | - |
State University of New York at Buffalo
| 5 years |
| David M. Ascher | M | - |
State University of New York at Buffalo
| 8 years |
| Douglas Reif | M | 70 |
State University of New York at Buffalo
| 6 years |
| Glenn I. Henricksen | M | 64 |
State University of New York at Buffalo
| 6 years |
| Gary P. Jacobi | M | - |
State University of New York at Buffalo
| 5 years |
| John Brodfuehrer | M | 66 |
State University of New York at Buffalo
| 4 years |
| Allene Diaz | F | 59 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| Deborah Brown | F | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 22 years |
| Alex Kuta | M | 64 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| David M. Thill | M | - |
Canisius College
| 4 years |
| Lewis I. Goldman | M | - |
State University of New York at Buffalo
| 3 years |
| Daniel Moynihan | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 12 years |
| Harvey L. Kaminski | M | - |
State University of New York at Buffalo
| 3 years |
| Ronald Lifton | M | 65 |
State University of New York at Buffalo
| 4 years |
| W. Anthony Sandonato | M | - |
State University of New York at Buffalo
| 4 years |
| Louis G. Henry | M | - |
State University of New York at Buffalo
| 4 years |
| James P. Griffin | M | - |
State University of New York at Buffalo
| 4 years |
| Siu Kin Fok | M | 70 |
State University of New York at Buffalo
| 4 years |
| James Smeeding | M | - |
State University of New York at Buffalo
| 4 years |
| Bob Schorr | M | - |
State University of New York at Buffalo
| 3 years |
| Amy Broidrick | F | 66 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Andy Hill | M | - |
Canisius College
| 4 years |
| Daguang Wang | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Joseph Poveromo | M | 77 |
State University of New York at Buffalo
| 3 years |
| Jerald Korn | M | 45 | 3 years | |
| Ernesto Aycardi | M | 61 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 1 years |
| Eric Lynn | M | - |
State University of New York at Buffalo
| 4 years |
| Helen Sabzevari | M | 62 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 6 years |
| Kim Wolin | F | 68 |
State University of New York at Buffalo
| 4 years |
| Paris Panayiotopoulos | M | 50 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| David Tuck | M | 72 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Mark DeLong | M | 47 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 11 years |
| Joseph Leveque | M | 63 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| James Nish | M | 65 |
State University of New York at Buffalo
| 4 years |
| Alise Reicin | M | 63 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Antonio Gualberto | M | 59 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Drew Young | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Gary Scheier | M | - |
State University of New York at Buffalo
| 4 years |
| Jason G. Duncan | M | 50 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Frederick E. Munschauer | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Richard Gluck | M | - |
State University of New York at Buffalo
| 4 years |
| Christopher J. Golinski | M | - |
Canisius College
| 2 years |
| Salvatore A. Esposito | M | - |
Canisius College
| 4 years |
| Mark Dzialga | M | 59 |
Canisius College
| 4 years |
| David Oppenheimer | M | 67 |
State University of New York at Buffalo
| 4 years |
| Frederick Muto | M | 70 |
State University of New York at Buffalo
| 4 years |
| Mark M. Sieczkarek | M | 69 |
State University of New York at Buffalo
| 4 years |
| Curt Launer | M | 68 |
State University of New York at Buffalo
| 4 years |
| Francis J. Boggan | M | - |
State University of New York at Buffalo
| 4 years |
| Jeffrey N. Meshulam | M | - |
State University of New York at Buffalo
| 4 years |
| Andrew B. Rosengard | M | - |
State University of New York at Buffalo
| 4 years |
| Craig R. Smith | M | 77 |
State University of New York at Buffalo
| 3 years |
| Jordan Levy | M | 68 |
State University of New York at Buffalo
| 4 years |
| Todd N. Tipton | M | 67 |
State University of New York at Buffalo
| 4 years |
| Louis Brenner | M | 54 | 4 years | |
| Jack Dempsey | M | 62 |
Canisius College
| 3 years |
| Joseph Nowicki | M | 62 |
Canisius College
| 4 years |
| Lewis Marks | M | 73 |
State University of New York at Buffalo
| 3 years |
| Richard D. Frederick | M | - |
State University of New York at Buffalo
| 3 years |
| David Sack | M | - |
State University of New York at Buffalo
| 4 years |
| Paul S. Molnar | M | 68 |
State University of New York at Buffalo
| 4 years |
| Martin J. Teitelbaum | M | 74 |
State University of New York at Buffalo
| 4 years |
| Robert M. Brenner | M | 56 | 2 years | |
| Richard Klenk | M | - |
State University of New York at Buffalo
| 4 years |
| Sherwood Klein | M | - |
State University of New York at Buffalo
| 4 years |
| John Huycke | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 9 years |
| John S. Malanowski | M | - |
State University of New York at Buffalo
| 4 years |
| Joe Frandina | M | - |
State University of New York at Buffalo
| 4 years |
| Marc E. Shapiro | M | 67 |
State University of New York at Buffalo
| 4 years |
| Joseph I. Rader | M | - |
State University of New York at Buffalo
| 4 years |
| Richard G. Couch | M | - |
State University of New York at Buffalo
| 1 years |
| Jack Ross | M | 67 |
State University of New York at Buffalo
| 4 years |
| Marc Tipermas | M | 76 |
State University of New York at Buffalo
| 2 years |
| Christopher M. Kelly | M | - |
Canisius College
| 4 years |
| James M. Craig | M | 67 |
State University of New York at Buffalo
| 4 years |
| Keith Blakely | M | - |
State University of New York at Buffalo
| 4 years |
| Martin J. Sumner | M | - |
State University of New York at Buffalo
| 4 years |
| Vijay Kasturi | M | 57 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.87% |
| Cayman Islands | 13 | 13.13% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gary Zieziula
- Personal Network
